Jia Yuanyuan, Dong Xiaosheng, Chai Yunlong, Bai Zhenmin, Sun Tingting, Hou Xiao
Key Laboratory of Sports and Physical Health Ministry of Education, Beijing Sport University, Beijing, China.
School of Sport Science, Beijing Sport University, Beijing, China.
BMJ Open. 2025 May 28;15(5):e087340. doi: 10.1136/bmjopen-2024-087340.
Chronic musculoskeletal pain (CMP) is a prevalent and distressing condition. Cupping therapy, one of the most popular complementary and alternative medicines, has been widely used to reduce CMP. But the evidence remains controversial on the effect of cupping therapy on CMP. The objective of this review and meta-analysis is to assess the effectiveness of cupping therapy in patients with CMP.
Systematic review and meta-analysis.
PubMed, Web of Science, EBSCO, Cochrane Library and CNKI (China National Knowledge Infrastructure) were searched through 20 December 2024.
We included randomised control trials that compared cupping therapy for patients with CMP on outcomes (ie, pain intensity, functional disability and mental health).
Two independent reviewers used standardised methods to search, screen and code included studies. Risk of bias was assessed using the Cochrane Collaboration and Evidence Project tools. Meta-analysis was conducted using random and fixed effects models. Findings were summarised in GRADE (Grading of Recommendations Assessment, Development and Evaluation) evidence profiles.
The results showed that cupping therapy (standardised mean difference (SMD)=-1.17; 95% CI=-1.93 to -0.42; p=0.002; I=94%) had a significant reduction effect on patients with CMP's pain intensity with moderate quality based on a random-effect model. But cupping therapy had no improvement effects on functional disability (SMD=-0.24; 95% CI=-0.93 to 0.46; p=0.51; I²=93%) and mental health (SMD=0.08; 95% CI=-0.12 to 0.27; p=0.46; I²=0%).
This study indicates that cupping therapy may be efficient in alleviating pain intensity in patients with CMP with immediate effects. But it cannot improve functional disability and mental health significantly.
CRD42023406219.
慢性肌肉骨骼疼痛(CMP)是一种常见且令人痛苦的病症。拔罐疗法作为最受欢迎的补充和替代医学之一,已被广泛用于减轻CMP。但关于拔罐疗法对CMP的疗效证据仍存在争议。本综述和荟萃分析的目的是评估拔罐疗法对CMP患者的有效性。
系统综述和荟萃分析。
检索了截至2024年12月20日的PubMed、科学网、EBSCO、考克兰图书馆和中国知网(中国国家知识基础设施)。
我们纳入了比较拔罐疗法对CMP患者结局(即疼痛强度、功能障碍和心理健康)影响的随机对照试验。
两名独立的评审员使用标准化方法对纳入的研究进行检索、筛选和编码。使用考克兰协作网和证据项目工具评估偏倚风险。使用随机效应模型和固定效应模型进行荟萃分析。研究结果在GRADE(推荐分级评估、制定和评价)证据概况中进行总结。
结果显示,基于随机效应模型,拔罐疗法(标准化均值差(SMD)=-1.17;95%置信区间=-1.93至-0.42;p=0.002;I²=94%)对CMP患者的疼痛强度有显著降低作用,质量中等。但拔罐疗法对功能障碍(SMD=-0.24;95%置信区间=-0.93至0.46;p=0.51;I²=93%)和心理健康(SMD=0.08;95%置信区间=-0.12至0.27;p=0.46;I²=0%)没有改善作用。
本研究表明,拔罐疗法可能对缓解CMP患者的疼痛强度有效,且效果立竿见影。但它不能显著改善功能障碍和心理健康。
PROSPERO注册号:CRD42023406219。